Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 29, 2015 - Issue 22
431
Views
16
CrossRef citations to date
0
Altmetric
Articles

A new butenolide cinnamate and other biological active chemical constituents from Polygonum glabrum

, , , , , , & show all
Pages 2080-2086 | Received 01 Dec 2014, Accepted 03 Jan 2015, Published online: 03 Feb 2015
 

Abstract

Phytochemical investigation of the methanol extract of the aerial parts of Polygonum glabrum afforded one new natural product ( − )-2-methoxy-2-butenolide-3-cinnamate (1) along with six known compounds, β-hydroxyfriedalanol (2), 3-hydroxy-5-methoxystilbene (3), ( − ) pinocembrin (4), sitosterol-(6′-O-palmitoyl)-3-O-β-d-glucopyranoside (5), ( − ) pinocembrin-5-methyl ether (6) and sitosterol-3-O-β-d-glucopyranoside (7). Compound 1 showed promising in vitro anti-HIV-1 activity against primary isolates HIV-1UG070 (X4, subtype D) and HIV-1VB59 (R5, subtype C) assayed using TZM-bl cell line with IC50 in the range of 15.68–22.43 μg/mL. The extract showed TI in the range of 19.19–27.37 with IC50 in the range of 10.90–15.55 μg/mL. Compounds 1, 3 and 4 exhibited in vitro anti-mycobacterium activity against Mycobacterium tuberculosis H37Ra with IC50 values of 1.43, 3.33 and 1.11 μg/mL in dormant phase and 2.27, 3.33 and 1.21 μg/mL in active phase, respectively. Compound 4 was found to be the most active antiproliferative with IC50 values of 1.88–11.00 μg/mL against THP-1, A549, Panc-1, HeLa and MCF7 cell lines.

Acknowledgements

We thank Dr. P. Tetali, NGCPR, Shirwal, Satara, for assistance in identifying P. glabrum.

Additional information

Funding

We are thankful to DBT-ICMR for their financial support to carry out the research.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.